Page 57 - 2023-06-中国全科医学

·698· http: //www.chinagp.net E-mail: zgqkyx@chinagp.net.cn February 2023, Vol.26 No.6

substantially increases the risk of adult depression and anxiety in ［25］KAPTAN S K，DURSUN B O，KNOWLES M，et al. Group eye
prospective cohort studies：systematic review，meta-analysis，and movement desensitization and reprocessing interventions in adults
proportional attributable fractions［J］. Psychol Med，2016，46（4）： and children：a systematic review of randomized and nonrandomized
717-730. DOI：10.1017/S0033291715002743. trials［J］. Clin Psychol Psychother，2021，28（4）：784-806.
［20］NELSON J，KLUMPARENDT A，DOEBLER P，et al. Childhood DOI：10.1002/cpp.2549.
maltreatment and characteristics of adult depression：meta- ［26］JAHANFAR A，FEREIDOUNI Z，BEHNAMMOGHADAM M，
analysis［J］. Br J Psychiatry，2017，210（2）：96-104. DOI： et al. Efficacy of eye movement desensitization and reprocessing
10.1192/bjp.bp.115.180752. on the quality of life in patients with major depressive disorder：a
［21］WIELAARD I，COMIJS H C，STEK M L，et al. Childhood randomized clinical trial［J］. Psychol Res Behav Manag，2020，
abuse and the two-year course of late-life depression［J］. Am J 13：11-17. DOI：10.2147/PRBM.S232589.
Geriatr Psychiatry，2017，25（6）：633-643. DOI：10.1016/j. ［27］YUNITRI N，KAO C C，CHU H，et al. The effectiveness of
jagp.2017.01.014. eye movement desensitization and reprocessing toward anxiety
［22］PAAUW C，DE ROOS C，TUMMERS J，et al. Effectiveness of disorder：a meta-analysis of randomized controlled trials［J］.
trauma-focused treatment for adolescents with major depressive J Psychiatr Res，2020，123：102-113. DOI：10.1016/j.
disorder［J］. Eur J Psychotraumatol，2019，10（1）：1682931. jpsychires.2020.01.005.
DOI：10.1080/20008198.2019.1682931. ［28］YAN S Y，SHAN Y Y，ZHONG S M，et al. The effectiveness of
［23］WINKLER O，DHALIWAL R，GREENSHAW A，et al. Web- eye movement desensitization and reprocessing toward adults with
based eye movement desensitization and reprocessing for adults major depressive disorder：a meta-analysis of randomized controlled
with suicidal ideation：protocol for a randomized controlled trials［J］. Front Psychiatry，2021，12：700458. DOI：
trial［J］. JMIR Res Protoc，2021，10（11）：e30711. DOI： 10.3389/fpsyt.2021.700458.
10.2196/30711. ［29］MINELLI A，ZAMPIERI E，SACCO C，et al. Clinical efficacy of
［24］FEREIDOUNI Z，BEHNAMMOGHADAM M，JAHANFAR A， trauma-focused psychotherapies in treatment-resistant depression
et al. The Effect of Eye Movement Desensitization and Reprocessing （TRD） in-patients：a randomized，controlled pilot-study［J］.
（EMDR） on the severity of suicidal thoughts in patients with Psychiatry Res，2019，273：567-574. DOI：10.1016/j.
major depressive disorder：a randomized controlled trial［J］. psychres.2019.01.070.
Neuropsychiatr Dis Treat，2019，15：2459-2466. DOI： （收稿日期：2022-07-26；修回日期：2022-10-17）
10.2147/NDT.S210757. （本文编辑：毛亚敏）

（上接第 691 页） 24-28. DOI：10.1177/0972753120929565.
［19］NOTO C，OTA V K，SANTORO M L，et al. Effects of depression ［24］王娟，杨亚婷，张雨龙，等 . 慢性精神分裂症患者血浆白介素
on the cytokine profile in drug naïve first-episode psychosis［J］. 17 与糖脂代谢的相关性研究［J］. 中国全科医学，2021，24（3）：
Schizophr Res，2015，164（1/2/3）：53-58. DOI：10.1016/j. 304-310. DOI：10.12114/j.issn.1007-9572.2020.00.493.
schres.2015.01.026. WANG J，YANG Y T，ZHANG Y L，et al. Relationship between
［20］AL-HAKEIM H K，AL-RAMMAHI D A，AL-DUJAILI A H. IL-17 level and glycolipid metabolism in patients with chronic
IL-6，IL-18，sIL-2R，and TNF alpha proinflammatory markers schizophrenia［J］. Chinese General Practice，2021，24（3）：
in depression and schizophrenia patients who are free of overt 304-310. DOI：10.12114/j.issn.1007-9572.2020.00.493.
inflammation ［J］. J Affect Disord，2015，182：106-114. DOI： ［25］GANGULI R，BRAR J S，CHENGAPPA K R，et al. Mitogen-
10.1016/j.jad.2015.04.044. stimulated interleukin-2 production in never-medicated，first-
［21］SUBBANNA M，SHIVAKUMAR V，TALUKDAR P M，et al.
episode schizophrenic patients. The influence of age at onset and
Role of IL-6/RORC/IL-22 axis in driving Th17 pathway mediated
negative symptoms［J］. Arch Gen Psychiatry，1995，52（8）：
immunopathogenesis of schizophrenia［J］. Cytokine，2018，
668-672. DOI：10.1001/archpsyc.1995.03950200058014.
111：112-118. DOI：10.1016/j.cyto.2018.08.016.
［26］DIMITROV D H，LEE S，YANTIS J，et al. Differential
［22］KÖHLER C A，FREITAS T H，MAES M，et al. Peripheral
correlations between inflammatory cytokines and psychopathology in
cytokine and chemokine alterations in depression：a meta-analysis
veterans with schizophrenia：potential role for IL-17 pathway［J］.
of 82 studies［J］. Acta Psychiatr Scand，2017，135（5）：373-
Schizophr Res，2013，151（1/3）：29-35. DOI：10.1016/j.
387. DOI：10.1111/acps.12698.
schres.2013.10.019.
［23］CHENNIAPPAN R，NANDEESHA H，KATTIMANI S，et al.
（收稿日期：2022-03-22；修回日期：2022-10-21）
Interleukin-17 and interleukin-10 association with disease
（本文编辑：贾萌萌）
progression in schizophrenia［J］. Ann Neurosci，2020，27（1）：